Hate to say it guys, but notwithstanding the Europe issue, the continued, slow, remorseless selldown from the Feb 29 JORC suggests to me that PEK in its current corporate guise may have a lot of trouble taking Ngualla forward.
A cornerstone investor from left field is one possible game changer.
- Forums
- ASX - By Stock
- PEK
- as a point of interest
as a point of interest, page-16
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEK (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $49.28M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 18.5¢ | $5.663K | 30.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 74391 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 33315 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 74391 | 0.185 |
8 | 350777 | 0.180 |
5 | 116924 | 0.175 |
9 | 236218 | 0.170 |
2 | 12500 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 33315 | 3 |
0.225 | 13300 | 1 |
0.230 | 5764 | 1 |
0.240 | 20000 | 1 |
0.250 | 70834 | 3 |
Last trade - 15.00pm 10/10/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online